The GW Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
NCT Number: NCT03078153
The purpose of this study is to determine if social media support and financial incentives improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24 living in the Washington, DC area who are at high risk for HIV acquisition.
Looking for future studies?
Notify Me18 year–24 year
Male
Interventional
Not applicable
Washington D.C., District of Columbia, 20037, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a $50 gift card at 3- and 6- month follow-up visits.
Participants will be invited to a study Facebook group which will have links to PrEP information and provide a forum for participants to ask questions and communicate their experience with PrEP
Time frame: 6 months
Level of Truvada drug levels inside red blood cells (performed by dried blood spots)
Time frame: 6 months
Number of reactive HIV rapid and 4th generation tests
Time frame: 6 months
Positive RPR, oropharyngeal/rectal/penile chlamydia and gonorrhea during study
George Washington University
Other
The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05664490
Behavior, Behavioral Symptoms
Johannesburg, Gauteng, South Africa
View Trial DetailsNCT06274060
Blood-Borne Infections, Communicable Diseases
Pietermaritzburg, KwaZulu-Natal, South Africa
View Trial DetailsNCT04222504
Behavior, Communicable Diseases
Durban, South Africa
View Trial DetailsNCT05243030
Pre-exposure Prophylaxis
Bangkok, Thailand
View Trial Details